Brought to you by 
SmithKline, Incyte form 50/50 diagnostics JV, diaDeXus LLC
Sep 1997
Executive Summary
SmithKline Beecham and Incyte (genomic databases) formed a 50/50 molecular diagnostics joint venture, diaDexus LLC, to develop tests based on genomic data from Incyte and SB/Human Genome Sciences databases.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- Joint Venture
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SmithKline, Incyte form 50/50 diagnostics JV, diaDeXus LLC
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice